Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2.

http://www.ncbi.nlm.nih.gov/pubmed/22988096

Parkinson disease (PD) results from the slow, progressive loss of dopaminergic neurons in the substantia nigra. Alterations in α-synuclein (aSyn), such as mutations or multiplications of the gene, are thought to trigger this degeneration. Here, we show that aSyn disrupts mitogen-activated protein kinase (MAPK)-controlled stress signaling in yeast and human cells, which results in inefficient cell protective responses and cell death. aSyn is a substrate of the yeast (and human) polo-like kinase Cdc5 (Plk2), and elevated levels of aSyn prevent Cdc5 from maintaining a normal level of GTP-bound Rho1, which is an essential GTPase that regulates stress signaling. The nine N-terminal amino acids of aSyn are essential for the interaction with polo-like kinases. The results support a unique mechanism of PD pathology.

Pubmed ID: 22988096 RIS Download

Mesh terms: Analysis of Variance | Bicyclo Compounds, Heterocyclic | Blotting, Western | Cell Line, Tumor | Humans | Microscopy, Fluorescence | Mitogen-Activated Protein Kinases | Nerve Degeneration | Parkinson Disease | Protein-Serine-Threonine Kinases | Signal Transduction | Thiazolidines | Yeasts | alpha-Synuclein | beta-Galactosidase

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: NS057656
  • Agency: NINDS NIH HHS, Id: R01 NS057656

BioGRID (Data, Interactions)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.